Đang chuẩn bị liên kết để tải về tài liệu:
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
KRAS mutations have been characterized as the major predictive biomarkers for resistance to cetuximab treatment. However, studies indicate that not all KRAS mutations are associated with equivalent treatment outcomes. | Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab